A challenge has been launched at the world’s biggest biotech event to advance 100 breakthroughs in the fight against cancer.
The Biotechnology Innovation Organization (BIO) is joining forces with the Center for Advancing Innovation (CAI) to advance the Freedom from Cancer Startup Challenge (FCSC), which will focus on prevention, detection and developing treatments. The pair introduced the initiative at this week’s BIO International Convention in San Diego.
Teams are invited to submit a business plan and pitch their technologies to a panel of judges. The winning teams will form companies and take forward their innovations to seek seed funding.
BIO will strive to inspire biotech stakeholders to take part as judges, mentors and advisors.
Jim Greenwood, BIO’s President and CEO, said: “CAI’s track record in launching Life Sciences startups is outstanding and the FCSC initiative further establishes a new paradigm to kick start new cancer companies and is a force multiplier for the oncology ecosystem. CAI’s systematic model establishes the trifecta necessary for high performing biotech companies – commercially viable inventions, rock star teams and funding – to get treatments to patients faster.”
Teams can apply from 1 August, and can visit here for more information.